0001104659-23-051214.txt : 20230427
0001104659-23-051214.hdr.sgml : 20230427
20230427144212
ACCESSION NUMBER: 0001104659-23-051214
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230427
DATE AS OF CHANGE: 20230427
EFFECTIVENESS DATE: 20230427
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RiverVest Venture Management LLC
CENTRAL INDEX KEY: 0001812549
IRS NUMBER: 431900629
STATE OF INCORPORATION: MO
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-21321
FILM NUMBER: 23855619
BUSINESS ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
BUSINESS PHONE: 314-726-6700
MAIL ADDRESS:
STREET 1: 101 S. HANLEY ROAD
STREET 2: SUITE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001812549
XXXXXXXX
03-31-2023
03-31-2023
false
RiverVest Venture Management LLC
101 S. Hanley Road
Suite 1850
St. Louis
MO
63105
13F HOLDINGS REPORT
028-21321
N
Sivan Weitzman
Chief Financial Officer
314-726-6700
/s/ Sivan Weitzman
St. Louis
MO
04-27-2023
0
6
86434658
INFORMATION TABLE
2
infotable.xml
Allakos, Inc.
Common
01671P100
21751297
4887932
SH
OTR
3349223
1538709
0
Spruce Bioscience, Inc.
Common
85209E109
6489180
2936281
SH
SOLE
2936281
0
0
Vapotherm, Inc.
Common
922107107
278414
423058
SH
OTR
0
423058
0
Mirum Pharmaceuticals, Inc.
Common
604749101
38939254
1621118
SH
SOLE
1621118
0
0
Reneo Pharmaceuticals, Inc.
Common
75974E103
14407136
2409220
SH
SOLE
2409220
0
0
Xilio Therapeutics, Inc.
Common
98422T100
4569377
1441444
SH
SOLE
1441444
0
0